Moderna’s Vaccine Reinvigorates Markets, but Long Winter Still on Tap

With another strong vaccine candidate emerging, markets are extending their "risk on" moves from last week...

Uptrend 3

Just a week after Pfizer and BioNTech announced interim results on their 90% effective COVID-19 vaccine, Moderna announced its trial vaccine was 94.5% effective in initial results this morning. Perhaps more importantly, there have been no severe cases among people who received the Moderna vaccine, a development that the company’s CEO classified as “a game-changer.” Both Pfizer and Moderna expect to seek emergency-us authorization from the FDA in the coming weeks, with distribution anticipated to start around the turn of the year.

The market reaction has been more muted than the response to the Pfizer vaccine results last week, but we’re seeing some of the same trend play out. Global equities are trading higher across the board, with the notable exception of “stay-at-home” US tech stocks (names like Zoom Video, Peloton Interactive, and Docusign). After rallying 7% last week alone, small capitalization stocks (a proxy for the “reopening trade”) are seeing another strong rally at the open:

Source: TradingView, GAIN Capital

As the chart above shows, the small-cap focused Russell 2000 is strongly outperforming the tech-heavy NASDAQ 100 over the last week, but it still has plenty of ground to make up to unwind the steep underperformance through the first half of the year.

In other markets, oil has caught a bid with the US benchmark WTI contract rallying nearly 5% so far, while gold is essentially flat on waning demand for safe-haven investments. Meanwhile, yields on the 10-year treasury bond are ticking higher to 0.91%. Finally, the trends in the FX market are reflecting the “risk on” sentiment that we’ve seen in other markets, with the “commodity dollars” (New Zealand, Australian, and Canadian dollars) leading the way, while the safe haven Swiss franc and Japanese yen bring up the rear:

Source: GAIN Capital, Eikon

 While today’s news is bullish and may help extend the nascent trends we saw start forming last week, readers should recognize that the “reopening trade” will not be a one-way street. With COVID infections surging across the Western world and hospitals overflowing in the hardest hit areas, there will still be plenty of back-and-forth trading opportunities as traders weigh the short-term pain against the long-term economic optimism.

More from Epidemic


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.